ÂÜÀòÂÒÂ×

Paul Zinter is currently the Vice President and Head of Sales in the Rare Disease Business at Acadia Pharmaceuticals Inc. Prior to their current role, Paul held leadership positions at various pharmaceutical companies, including Zealand Pharma, Sage Therapeutics, Biogen, Purdue Pharma L.P., and AstraZeneca. Paul holds an MBA from Northwestern University - Kellogg School of Management and a Bachelor of Science in Business Administration and Marketing from the University of Central Florida.